• About us
• Contact

Advertisement

Organisation › Details

Biocrates (Group)

biocrates life sciences ag is a world leader in quantitative, mass-spectrometry-based metabolomics. Founded in 2002 and headquartered in Innsbruck, Austria, the company delivers standardized kits, software and contract research services that enable laboratories to quantify up to 1,881 biomarkers in a single kit from less than one drop of blood. Researchers worldwide rely on flagship kits such as MxP® Quant 1000 to transform metabolic data from diverse tissues and sample types into clearer biomarkers, accelerated drug development and more precise healthcare. *

 

	Start	2002-01-01 established (s-off)
	Group	Bruker (Group)
	Today	Bruker (Group)
	Predecessor	Medical University Innsbruck (MUI)
	Successor	Bruker (Group)
	Industry	AbsoluteIDQ® Kit
	Industry 2	metabolomics
	Person	Schauer, Nicolas (Certania 202409– Managing Director of Alphalytik formerly Biocrates + Metabolomic Discoveries)
	Person 2	Seuster, Moritz (Biocrates 201909– Co-CEO + CFO before 201906 CFO + 201903– Managing Director of Metanomics Health GmbH)
	Region	Innsbruck
	Country	Austria
	Street	8 Eduard-Bodem-Gasse
	City	6020 Innsbruck
	Tel	+43-512-579823
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Bruker Corporation. (6/3/25). "Press Release: Bruker Announces Acquisition of Biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics". Innsbruck.
		Record changed: 2026-05-17

Advertisement

More documents for Bruker (Group)

• [1] Bruker Corporation. (8/11/26). "Press Release: Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories". Boston, MA....
• [2] Bruker Corporation. (8/10/26). "Press Release: Bruker Reports Second Quarter 2026 Financial Results". Billerica, MA....
• [3] Bruker Corporation. (8/10/26). "Press Release: Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development". Leiden....
• [4] Bruker Corporation. (7/15/26). "Press Release: Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER Platform for Pathogenic Microorganisms in Blood". Bremen....
• [5] Bruker Corporation. (6/4/26). "Press Release: Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026". Washington, DC....
• [6] Bruker Corporation. (6/2/26). "Press Release: Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry". San Diego, CA....
• [7] Bruker Corporation. (5/26/26). "Press Release: Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI". Billerica, MA....
• [8] Bruker Corporation. (5/26/26). "Press Release: Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – All to Enable Deep...
• [9] Bruker Corporation. (5/6/26). "Press Release: Bruker Reports First Quarter 2026 Financial Results". Billerica, MA....
• [10] Bruker Corporation. (4/17/26). "Press Release: Bruker Launches MyGenius PRO High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026". Munich....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.